{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:48Z","timestamp":1787026968162,"version":"build-2736575974"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010716","name":"Magistrat der Stadt Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003494","name":"Herzfelder'sche Familienstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Ovarian cancer(OC) is a serious threat to women worldwide. Peritoneal dissemination, ascites and omental metastasis are typical features for disease progression, which occurs in a micro-environment that is rich in high-energy lipids. OC cells require high amounts of lipids for survival and growth. Not only do they import lipids from the host, they also produce lipids\n                    <jats:italic>de novo<\/jats:italic>\n                    . Inhibitors of fatty acid(FA) synthase(FASN) \u2013 the rate-limiting enzyme of endogenous FA synthesis that is overexpressed in OC \u2013 induce growth-arrest and apoptosis, rendering them promising candidates for cancer drug development. However, cancer researchers have long hypothesized that the lipid deficiency caused by FASN inhibition can be circumvented by increasing the uptake of exogenous lipids from the host, which would confer resistance to FASN inhibitors. In contrast to a very recent report in colorectal cancer, we demonstrate in OC cells (A2780, OVCAR3, SKOV3) that neither FASN inhibitors (G28UCM, Fasnall) nor FASN-specific siRNAs can stimulate a relief pathway leading to enhanced uptake of extrinsic FAs or low density lipoproteins (LDLs). Instead, we observed that the growth-arrest due to FASN inhibition or FASN knock-down was associated with significant dose- and time-dependent reduction in the uptake of fluorescently labeled FAs and LDLs. Western blotting showed that the expression of the FA receptor CD36, the LDL receptor(LDLR) and the lipid transport proteins fatty acid binding proteins 1\u20139 (FABP1\u20139) was not affected by the treatment. Next, we compared experimental blockade of endogenous lipid production with physiologic depletion of exogenous lipids. Lipid-free media, similar to FASN inhibitors, caused growth-arrest. Although lipid-depleted cells have diminished amounts of CD36, LDLR and FABPs, they can still activate a restorative pathway that causes enhanced import of fluorophore-labeled FAs and LDLs. Overall, our data show that OC cells are strictly lipid-depend and exquisitely sensitive to FASN inhibitors, providing a strong rationale for developing anti-FASN strategies for clinical use against OC.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2021.610885","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:32:55Z","timestamp":1618281175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells"],"prefix":"10.3389","volume":"11","author":[{"given":"Thomas W.","family":"Grunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"L\u00f3pez\u2212Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14591","article-title":"Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells","volume":"8","author":"Wagner","year":"2017","journal-title":"Oncotarget"},{"key":"B3","unstructured":"Ovary Cancer2020"},{"key":"B4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s42003-019-0508-1","article-title":"Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells","volume":"2","author":"Chen","year":"2019","journal-title":"Commun Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.11.034","article-title":"Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer","volume":"388","author":"Auer","year":"2017","journal-title":"Cancer Lett"},{"key":"B6","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14877","DOI":"10.1038\/s41598-020-71491-z","article-title":"Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer","volume":"10","author":"Grunt","year":"2020","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tem.2017.11.003","article-title":"Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics","volume":"29","author":"Grunt","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"B10","article-title":"Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer","volume":"56","author":"Pizer","year":"1996","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2013.03.010","article-title":"The fat side of prostate cancer","volume":"1831","author":"Zadra","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","article-title":"CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies","volume":"29","author":"Feng","year":"2019","journal-title":"Cell Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01185","article-title":"Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells","volume":"10","author":"Drury","year":"2020","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.103.2.501","article-title":"Comparative analysis of the effects of dimethyl sulfoxide and retinoic acid on the antigenic pattern of human ovarian adenocarcinoma cells","volume":"103","author":"Grunt","year":"1992","journal-title":"J Cell Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131241","article-title":"Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs","volume":"10","author":"Blancafort","year":"2015","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0856","article-title":"Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity","volume":"15","author":"Puig","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/jm2016045","article-title":"New synthetic inhibitors of fatty acid synthase with anticancer activity","volume":"55","author":"Turrado","year":"2012","journal-title":"J Med Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2016.04.011","article-title":"Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer","volume":"23","author":"Alwarawrah","year":"2016","journal-title":"Cell Chem Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9570","article-title":"Retinoids control the expression of c-erbB receptors in breast cancer cells","volume":"251","author":"Offterdinger","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006377006816","article-title":"Involvement of nuclear steroid\/thyroid\/retinoid receptors and of protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells","volume":"58","author":"Schneider","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.085","article-title":"Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells","volume":"385","author":"Grunt","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0467","article-title":"Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer","volume":"9","author":"Tomek","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-010-1232-1","article-title":"The PI3 kinase\/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells","volume":"129","author":"Br\u00fcnner-Kubath","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2174\/092986706776361012","article-title":"Inhibition of fatty acid synthase by polyphenols","volume":"13","author":"Tian","year":"2006","journal-title":"Curr Med Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/bcr3077","article-title":"A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines","volume":"13","author":"Puig","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29261","article-title":"Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells","volume":"136","author":"Veigel","year":"2015","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12987","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25126","article-title":"Role of tumor microenvironment in ovarian cancer pathobiology","volume":"9","author":"Ghoneum","year":"2018","journal-title":"Oncotarget"},{"key":"B31","unstructured":"TVB26402020"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.06.020","article-title":"Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression","volume":"2","author":"Ventura","year":"2015","journal-title":"EBioMedicine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2020.104707","article-title":"Anticancer properties of the fatty acid synthase inhibitor TVB-3166 on oral squamous cell carcinoma cell lines","volume":"113","author":"Aquino","year":"2020","journal-title":"Arch Oral Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ebiom.2016.12.012","article-title":"FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression","volume":"16","author":"Heuer","year":"2017","journal-title":"EBioMedicine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27129","article-title":"Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT\/mTOR\/SREBP-1c axis","volume":"234","author":"Tao","year":"2019","journal-title":"J Cell Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.04.023","article-title":"Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models","volume":"183","author":"Clark","year":"2013","journal-title":"Am J Pathol"},{"key":"B37","article-title":"Effects of DL-alphamethylornithine on proliferation and polyaminecontent of 9L rat brain tumor cells","volume":"40","author":"Seidenfeld","year":"1980","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.1.7.594","article-title":"Cell cycle parameters of Chinese hamster ovary cells during exponential, polyamine-limited growth","volume":"1","author":"Harada","year":"1981","journal-title":"Mol Cell Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.610885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T13:32:00Z","timestamp":1619875920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.610885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":38,"alternative-id":["10.3389\/fonc.2021.610885"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.610885","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"article-number":"610885"}}